Judge Considers Delaying CVS-Aetna Merger, Citing Potential Anti-Competitive Harms

This post was originally published on this site

But antitrust experts say it’s only possible for the Department of Justice to block the merger. DOJ approved the $70 billion deal in October. Meanwhile, CVS and Aetna are moving ahead with integration plans. Other industry news looks at CVS’ new prescription drug-price plans and rising costs of Pitocin and Ketamine.